Tyra Biosciences, Inc.TYRANASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+31.1%
5Y CAGR+70.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+31.1%/yr
Annual compound
5Y CAGR
+70.4%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
14.4x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $132.76M | +27.4% |
| 2024 | $104.18M | +30.3% |
| 2023 | $79.94M | +35.7% |
| 2022 | $58.93M | +124.2% |
| 2021 | $26.29M | +184.2% |
| 2020 | $9.25M | +196.3% |
| 2019 | $3.12M | - |